MetLife Investment Management, LLC - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 132 filers reported holding BRIDGEBIO PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$1,592,484
+53.3%
60,3900.0%0.01%
+62.5%
Q2 2023$1,038,708
+12.5%
60,390
+8.5%
0.01%
+14.3%
Q1 2023$923,025
+107.3%
55,671
-4.7%
0.01%
+75.0%
Q4 2022$445,343
-23.3%
58,4440.0%0.00%
-20.0%
Q3 2022$580,933
+9.5%
58,4440.0%0.01%
+25.0%
Q2 2022$530,672
-10.5%
58,4440.0%0.00%0.0%
Q1 2022$593,207
-7.2%
58,444
+52.5%
0.00%
-20.0%
Q4 2021$639,294
-64.4%
38,3270.0%0.01%
-70.6%
Q3 2021$1,796,387
-23.1%
38,3270.0%0.02%
-22.7%
Q2 2021$2,336,414
+10.0%
38,327
+11.2%
0.02%
+10.0%
Q1 2021$2,123,106
-0.0%
34,466
+15.4%
0.02%
-9.1%
Q4 2020$2,123,416
+76.3%
29,861
-7.0%
0.02%
+69.2%
Q3 2020$1,204,317
+15.1%
32,0980.0%0.01%
+8.3%
Q2 2020$1,046,716
+12.4%
32,0980.0%0.01%
-7.7%
Q1 2020$930,842
+159.5%
32,098
+213.6%
0.01%
+225.0%
Q4 2019$358,737
+12.0%
10,235
-31.4%
0.00%0.0%
Q3 2019$320,26814,9170.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$60,317,00040.05%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$308,746,0006.20%
M28 Capital Management LP 513,300$5,102,0005.33%
GREAT POINT PARTNERS LLC 1,050,000$10,437,0002.51%
Octagon Capital Advisors LP 933,743$9,281,0001.60%
HHLR ADVISORS, LTD. 5,362,014$53,298,0001.40%
VIKING GLOBAL INVESTORS LP 26,620,991$264,613,0001.22%
Cormorant Asset Management, LP 1,469,179$14,604,0001.02%
Fernwood Investment Management, LLC 204,550$2,033,0000.86%
TANG CAPITAL MANAGEMENT LLC 585,424$5,819,0000.71%
View complete list of BRIDGEBIO PHARMA INC shareholders